Tessera Therapeutics to Present New Preclinical Data Supporting In Vivo Program in Sickle Cell Disease and Advancements in In Vivo CAR-T Applications at the American Society of Gene and Cell Therapy 29th Annual Meeting

On April 27, 2026 Tessera Therapeutics ("Tessera"), the biotechnology company pioneering a new approach in genetic medicine known as Gene Writing, reported four presentations of new preclinical data at the upcoming American Society of Gene and Cell Therapy (ASGCT) (Free ASGCT Whitepaper) Annual Meeting taking place in Boston, Massachusetts, May 11 – 15, 2026.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Details of the Company’s ASGCT (Free ASGCT Whitepaper) 29th Annual Meeting presentations are as follows:

Oral presentations:

Title: Therapeutically relevant levels of in vivo HBB gene correction in Hematopoietic Stem Cells for the treatment of Sickle Cell Disease
Session: Advances in stem cell–directed gene therapy: Platforms, safety, and translation
Presenter: Giulia Schiroli, Ph.D.
Date and Time: May 12, 2026, 8:15 a.m. – 8:30 a.m. ET
Location: MCEC Room 206AB (Level 2)

Title: RNA Delivery by Targeted Lipid Nanoparticles Enable In Vivo Genome Editing of Hematopoietic Stem Cells and T Cells
Session: LNPs for in vivo CAR-T applications
Presenter: Mike Monte, Ph.D.
Date and Time: May 12, 2026, 8:30 a.m. – 8:45 a.m. ET
Location: MCEC Room 210ABC (Level 2)

Title: Targeted LNP Delivery of an RNA Gene Writer In Vivo Enables Generation of Functional CAR-T Cells in Animal Models
Session: In Vivo Engineering of CAR T-cells for Autoimmune Disease
Presenter: Alberto De Iaco, Ph.D.
Date and Time: May 14, 2026, 11:45 a.m. – 12:00 p.m. ET
Location: Westin Seaport Grand Ballroom CDE (Concourse Level)

Scientific Symposia:

Title: Characterization of LNP biophysical properties and impact on efficacy in vivo
Session: The biologic and biophysical challenges of LNP delivery: Opportunities to improve safety and efficacy
Presenter: Tom Colace, Ph.D.
Date and Time: May 15, 2026, 3:30 p.m. – 4:00 p.m. ET
Location: MCEC Room 107ABC (Level 1)

(Press release, Tessera Therapeutics, APR 27, 2026, View Source [SID1234664832])